Latest DAFNA Capital Management LLC Stock Portfolio
$418Million– No. of Holdings #82
DAFNA Capital Management LLC Performance:
2024 Q2: -8.62%YTD: 5.39%2023: 5.58%
Performance for 2024 Q2 is -8.62%, and YTD is 5.39%, and 2023 is 5.58%.
About DAFNA Capital Management LLC and 13F Hedge Fund Stock Holdings
DAFNA Capital Management LLC is a hedge fund based in LOS ANGELES, CA. On 30-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $542.7 Millions. In it's latest 13F Holdings report, DAFNA Capital Management LLC reported an equity portfolio of $418.6 Millions as of 30 Jun, 2024.
The top stock holdings of DAFNA Capital Management LLC are BIL, STXS, MRUS. The fund has invested 9.9% of it's portfolio in SPDR S&P BIOTECH ETF and 6% of portfolio in STEREOTAXIS INC.
The fund managers got completely rid off PERSPECTIVE THERAPEUTICS INC and VIGIL NEUROSCIENCE INC (VIGL) stocks. They significantly reduced their stock positions in PROCEPT BIOROBOTICS CORP (PRCT), MEDIWOUND LTD and TANDEM DIABETES CARE INC (TNDM). DAFNA Capital Management LLC opened new stock positions in UROGEN PHARMA LTD (URGN), ALKERMES PLC (ALKS) and PERSPECTIVE THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to ALTO NEUROSCIENCE INC, ATRICURE INC (ATRC) and IMMUNOVANT INC (IMVT).
The top stock holdings of DAFNA Capital Management LLC are BIL, STXS, MRUS. The fund has invested 9.9% of it's portfolio in SPDR S&P BIOTECH ETF and 6% of portfolio in STEREOTAXIS INC.
The fund managers got completely rid off PERSPECTIVE THERAPEUTICS INC and VIGIL NEUROSCIENCE INC (VIGL) stocks. They significantly reduced their stock positions in PROCEPT BIOROBOTICS CORP (PRCT), MEDIWOUND LTD and TANDEM DIABETES CARE INC (TNDM). DAFNA Capital Management LLC opened new stock positions in UROGEN PHARMA LTD (URGN), ALKERMES PLC (ALKS) and PERSPECTIVE THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to ALTO NEUROSCIENCE INC, ATRICURE INC (ATRC) and IMMUNOVANT INC (IMVT).
DAFNA Capital Management LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2024
DAFNA Capital Management LLC Annual Return Estimates Vs S&P 500
Our best estimate is that DAFNA Capital Management LLC made a return of -8.62% in the last quarter. In trailing 12 months, it's portfolio return was 14.21%.
New Buys
| Ticker | $ Bought |
|---|---|
| urogen pharma ltd | 7,869,820 |
| alkermes plc | 2,908,870 |
| perspective therapeutics inc | 2,309,390 |
| allogene therapeutics inc | 1,409,880 |
| sage therapeutics inc | 1,261,930 |
| centessa pharmaceuticals plc | 1,109,620 |
| tourmaline bio inc | 977,129 |
| nyxoah s a | 753,513 |
New stocks bought by DAFNA Capital Management LLC
Additions
| Ticker | % Inc. |
|---|---|
| alto neuroscience inc | 1,100 |
| acelyrin inc | 242 |
| atricure inc | 135 |
| biohaven ltd | 84.22 |
| immunovant inc | 62.89 |
| autolus therapeutics plc | 60.00 |
| iteos therapeutics inc | 46.47 |
| stoke therapeutics inc | 43.05 |
Additions to existing portfolio by DAFNA Capital Management LLC
Reductions
| Ticker | % Reduced |
|---|---|
| procept biorobotics corp | -74.55 |
| mediwound ltd | -34.05 |
| tandem diabetes care inc | -20.91 |
| regulus therapeutics inc | -16.38 |
| 2seventy bio inc | -12.74 |
| ascendis pharma a/s | -12.44 |
| acrivon therapeutics inc | -7.61 |
| ideaya biosciences inc | -5.41 |
DAFNA Capital Management LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| perspective therapeutics inc | -3,693,340 |
| vigil neuroscience inc | -244,889 |
| biontech se | -1,568,250 |
DAFNA Capital Management LLC got rid off the above stocks
Sector Distribution
DAFNA Capital Management LLC has about 76.1% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 76.1 |
| Others | 23.4 |
Market Cap. Distribution
DAFNA Capital Management LLC has about 4.9% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 32.4 |
| SMALL-CAP | 27.9 |
| UNALLOCATED | 23.8 |
| MICRO-CAP | 10.9 |
| LARGE-CAP | 4.9 |
Stocks belong to which Index?
About 54% of the stocks held by DAFNA Capital Management LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 51.4 |
| Others | 46 |
| S&P 500 | 2.6 |
DAFNA Capital Management LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of DAFNA Capital Management LLC
DAFNA Capital Management LLC has 82 stocks in it's portfolio. About 47.8% of the portfolio is in top 10 stocks. STXS proved to be the most loss making stock for the portfolio. MRUS was the most profitable stock for DAFNA Capital Management LLC last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACET | adicet bio inc | 0.17 | 600,000 | 726,000 | unchanged | 0.00 | ||
| ADAP | adaptimmune therapeutics plc | 0.08 | 341,064 | 332,503 | unchanged | 0.00 | ||
| ADCT | adc therapeutics sa | 0.15 | 204,081 | 644,896 | new | |||
| ALEC | alector inc | 0.99 | 912,928 | 4,144,690 | unchanged | 0.00 | ||
| ALKS | alkermes plc | 0.70 | 120,700 | 2,908,870 | new | |||
| ALLO | allogene therapeutics inc | 0.34 | 605,100 | 1,409,880 | new | |||
| APRE | aprea therapeutics inc | 0.13 | 137,174 | 558,298 | unchanged | 0.00 | ||
| AQST | aquestive therapeutics inc | 0.33 | 530,000 | 1,378,000 | added | 6.00 | ||
| ARAY | accuray inc | 0.53 | 1,222,360 | 2,224,690 | unchanged | 0.00 | ||
| ATRC | atricure inc | 3.48 | 639,173 | 14,554,000 | added | 135 | ||
| ATXS | astria therapeutics inc | 0.60 | 274,165 | 2,494,900 | added | 22.8 | ||
| AUTL | autolus therapeutics plc | 0.29 | 346,667 | 1,206,400 | added | 60.00 | ||
| AXGN | axogen inc | 1.62 | 935,894 | 6,775,870 | unchanged | 0.00 | ||
| BCRX | biocryst pharmaceuticals inc | 1.04 | 704,500 | 4,353,810 | reduced | -0.7 | ||
| BCYC | bicycle therapeutics plc | 0.59 | 122,200 | 2,473,330 | unchanged | 0.00 | ||
| BIL | spdr s&p biotech etf | 9.86 | 445,005 | 41,256,400 | added | 3.2 | ||
| BPMC | blueprint medicines corp | 2.70 | 104,763 | 11,291,400 | reduced | -1.87 | ||
| CMPS | compass pathways plc | 0.35 | 243,210 | 1,468,990 | unchanged | 0.00 | ||
| CMPX | compass therapeutics inc | 0.03 | 116,882 | 116,882 | unchanged | 0.00 | ||
| CNTA | centessa pharmaceuticals plc | 0.26 | 122,882 | 1,109,620 | new | |||